H.U. Group Holdings, Inc. revised consolidated earnings guidance for the fiscal year ending March 31, 2024. The company now expects net sales of ¥236,900 million against previous guidance of ¥240,000 million; operating loss of ¥4,100 million against previous guidance of operating profit of ¥4,000 million; loss attributable to owners of parent of ¥7,400 million or ¥130.08 per share against previous guidance of ¥0 million or ¥0.00 per share. Reasons for revisions: The Company anticipates a decrease in net sales of approximately ¥3.1 billion (-1.3%) compared to the previous forecast.

This decline is attributed to lower-than-expected testing volumes in the base business, which were expected to recover in the fourth quarter, as well as a decrease in COVID-19-related tests, which were projected to increase. Operating profit is anticipated to decrease by approximately ¥8.1 billion compared to the previous forecast, by reason of the aforementioned factors, along with the delayed effects of profitability improvement initiatives, primarily within the Lab Testing and its related Services business. Profit attributable to owners of the parent is anticipated to decrease by approximately ¥7.4 million compared to the previous forecast on account of the decrease in ordinary profit.